|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.790 USD | 0.00% |
|
-14.76% | +30.66% |
| Market Cap | 62Cr 54Cr 50Cr 46Cr 87Cr 5.95TCr 88Cr 595.5Cr 234.22Cr 2.91TCr 232.02Cr 226.93Cr 10TCr | P/E 2026 * |
-2.52x | P/E 2027 * | -2.35x |
|---|---|---|---|---|---|
| Enterprise Value | 43Cr 38Cr 35Cr 32Cr 61Cr 4.16TCr 62Cr 416.53Cr 163.83Cr 2.04TCr 162.29Cr 158.73Cr 7.02TCr | EV / Sales 2026 * |
64,789x | EV / Sales 2027 * | 35.4x |
| Free-Float |
83.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 week | -14.76% | ||
| Current month | -13.94% | ||
| 1 month | -5.79% | ||
| 3 months | -24.47% | ||
| 6 months | +9.82% | ||
| Current year | +30.66% |
| 1 week | 1.74 |  | 1.97 |
| 1 month | 1.74 | | 2.25 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
Franz Humer
BRD | Director/Board Member | 79 | 01/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Free | Chief Executive Officer | 6,10,720 | 0.1769% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -14.76% | +45.53% | -63.91% | 62Cr | |
| -7.17% | -2.63% | +49.59% | +74.24% | 5.6TCr | |
| +0.24% | -5.62% | +54.73% | +125.15% | 5.37TCr | |
| +0.80% | -8.41% | +3.57% | +425.83% | 2.33TCr | |
| -0.09% | -1.61% | -18.68% | -15.48% | 2.32TCr | |
| -5.95% | -0.22% | +35.96% | -9.58% | 2.06TCr | |
| -1.14% | -3.16% | +32.88% | -28.80% | 1.78TCr | |
| -5.16% | -7.00% | +177.56% | +326.39% | 1.61TCr | |
| -6.91% | +2.40% | +36.86% | +636.97% | 1.59TCr | |
| +0.43% | -2.07% | +24.79% | +188.40% | 1.4TCr | |
| Average | -2.48% | -2.61% | +44.28% | +165.92% | 2.41TCr | |
| Weighted average by Cap. | -2.90% | -2.23% | +43.59% | +156.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.67T 5.83T 5.38T 4.96T 9.34T 6L 9.55T 64.29T 25.29T 3L 25.05T 24.5T 10.83L | 1.46Cr 1.28Cr 1.18Cr 1.08Cr 2.04Cr 140.55Cr 2.09Cr 14Cr 5.53Cr 69Cr 5.48Cr 5.36Cr 236.96Cr |
| Net income | -20Cr -17Cr -16Cr -15Cr -28Cr -1.9TCr -28Cr -190.22Cr -75Cr -930.78Cr -74Cr -72Cr -3.2TCr | -23Cr -20Cr -19Cr -17Cr -32Cr -2.23TCr -33Cr -222.71Cr -88Cr -1.09TCr -87Cr -85Cr -3.75TCr |
| Net Debt | -19Cr -16Cr -15Cr -14Cr -26Cr -1.79TCr -27Cr -178.97Cr -70Cr -875.77Cr -70Cr -68Cr -3.01TCr | -10Cr -8.81Cr -8.13Cr -7.49Cr -14Cr -970.69Cr -14Cr -97Cr -38Cr -475.4Cr -38Cr -37Cr -1.64TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $1.790 | 0.00% | 49,39,518 |
| 16/26/16 | $1.790 | -5.79% | 63,00,098 |
| 15/26/15 | $1.900 | +2.70% | 60,39,901 |
| 14/26/14 | $1.850 | -4.15% | 54,22,350 |
| 13/26/13 | $1.930 | -3.50% | 89,41,923 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
